acamprosate has been researched along with ascorbic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bal, R; Calişkan, AM; Calişkan, S; Naziroğlu, M; Ovey, IS; Ozcankaya, R; Sütçü, R; Uğuz, AC | 1 |
1 review(s) available for acamprosate and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for acamprosate and ascorbic acid
| Article | Year |
|---|---|
Acamprosate modulates alcohol-induced hippocampal NMDA receptors and brain microsomal Ca2+-ATPase but induces oxidative stress in rat.
Topics: Acamprosate; Alcohol Deterrents; Animals; Ascorbic Acid; beta Carotene; Calcium-Transporting ATPases; Glutathione Peroxidase; Hippocampus; Lipid Peroxidation; Male; Microsomes; Oxidative Stress; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Taurine; Vitamin E | 2010 |